Author:
Miyashita Mariko,Koga Kaori,Izumi Gentaro,Makabe Tomoko,Hasegawa Akiko,Hirota Yasushi,Hirata Tetsuya,Harada Miyuki,Fujii Tomoyuki,Osuga Yutaka
Subject
Obstetrics and Gynaecology,Reproductive Medicine
Reference37 articles.
1. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential;Fuhrmann;Contraception,1996
2. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity;Muhn;Ann N Y Acad Sci,1995
3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism;Oelkers;J Clin Endocrinol Metab,1995
4. Do low-dose oral contraceptives have an effect on ovarian endometrioma diameter and endometriosis symptoms?;Del Forno;J Endometr Pelvic Pain Dis,2013
5. A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcg;Mabrouk;Gynecol Endocrinol,2012
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献